Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

I've had Theravance Biopharma for a little over a year now. It has around the same 300 people with a $1.7 Bil value. How would you say this compares?

THERAPEUTIC AREA

INFECTIOUS DISEASE:

VIBATIV® (tela9vancin): cSSSI, HABP/VABP, Bacteremia (Approved)
Telavancin: Primary Bacteremia (TBPH) (Ph III)
Cefilavancin (TD-1792): Gram+ MRSA (R-Pharm Ex USA)(PH III)
TD-6450: HCV (TREK THERA) (PH II)
TD-1607:Gram+ MRSA (TBPH) (PH II)

RESPIRATORY:
Revefenacin (TD-4208): COPD (Mylan) (Ph III)

GASTROINTESTINAL:
Axelopran (TD-1211): OIC (TBPH) (Ph II)
Axelopran (TD-1211)/Opiod FDC: Pain (TBPH) (Ph II)
Velusetrag: Gastroparesis (Alfa Wassermann ex-U.S.) (Ph II)
TD-8954: ICU IV Prokinetic (Takeda) (Ph II)
TD-1473: Ulcerative Colitis (TBPH) (Ph I)

CARDIOVASCULAR:
TD-0714, TD-1439 : Heart Failure, Chronic Kidney Disease (TBPH) Ph II
TD-9855: nOH (TBPH) (Ph II)

ECONOMIC INTERESTS:
Closed Triple (FF/UMEC/VI): COPD (GSK & Innoviva, Inc.) (PH III Complete)
Closed Triple (FF/UMEC/VI): Asthma (GSK & Innoviva, Inc.) (Ph III)
MABA, MABA/ICS (batefenterol, batefenterol/FF):COPD (GSK) (Ph III)